Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Sep 21 2026 8:59 AM

Full Issue

Jehovah’s Witnesses To Allow Use Of Blood Donation Derivatives For Medical Use

According to the religious organization's second rule revision this year, members may receive medical treatments that use any of the four main components of whole blood: plasma, platelets, and red and white blood cells, AP reported. However, transfusions of whole blood are still banned.

AP: Jehovah’s Witnesses Partly Ease Ban On Medical Use Of Donated Blood

The Jehovah’s Witnesses have partly eased their longstanding prohibition on the medical use of donated blood, allowing members to receive products derived from blood but maintaining a ban on transfusions of whole blood. The policy, announced Friday, is the second revision this year in what has long been one of the most controversial and distinctive teachings of the religious organization. (Smith, 9/18)

On kidney disease, fatigue, cancer, and sunscreen —

The Hill: Kidney Disease Of Unknown Origin Spreads In US. Who Is At Risk?

Doctors in Texas say they have seen an increasing number of otherwise healthy young men coming in on the brink of organ failure. The health care practitioners told Texas Monthly they believe the culprit is CKDu, or chronic kidney disease of unknown origin, an unexplained form of kidney disease that can quickly turn deadly. (Martichoux, 9/20)

Fox News: CDC New Report Finds 71% Of U.S. Adults Experience Fatigue Regularly

Exhaustion has become the default state for a vast majority of Americans. Data from the Centers for Disease Control and Prevention’s National Center for Health Statistics shows that more than seven in 10 U.S. adults experience fatigue over any given three-month period — a drain that public health officials say is taking a heavy toll on work and daily life. (Quill, 9/17)

Phys.org: Loss Of Y Chromosome In Men Could Be An Early Warning Sign Of Cancer

A study initiated by Dr. Dan Theodorescu, a physician-scientist at the University of Arizona Cancer Center, revealed that the loss of the Y chromosome in men's body tissue could pave the way for cancer to develop. According to research recently published in JCI Insights, the loss of the chromosome, which is common in men as they age, creates a preneoplastic field effect, a hidden zone of genetic vulnerability in normal tissue that provides fertile ground for cancer to develop. (9/19)

The Washington Post: A Melanoma Vaccine Was Hailed As A Breakthrough. Which Cancers Are Next?

The reported success of an experimental drug that uses messenger RNA to deliver personalized skin cancer vaccines could herald a wave of new treatments that harness the potent technology for a range of cancers, researchers say. Drugmakers Moderna and Merck this summer announced that a cancer vaccine, intismeran autogene, had succeeded in a Phase 3 clinical trial in preventing the recurrence of melanoma, a result experts celebrated as a breakthrough for mRNA-based cancer treatments. (Wu, 9/19)

STLPR: A New Sunscreen Ingredient Is Coming To A Store Near You. Here’s Why That’s A Big Deal

By the end of the year, U.S. consumers will see a new sun protection option on store shelves. The products will be especially beneficial to those with fair skin and hair, as well as light-colored eyes, autoimmune conditions like lupus and a predisposition to skin cancer, in addition to those wanting to curb the aging effects of sun exposure. (Cha, 9/18)

On autism and Down syndrome —

CIDRAP: Study Uncovers No Evidence Of Autism Epidemic, Despite Claims

Many people, including US Health and Human Services Secretary Robert F. Kennedy Jr., say that autism rates have reached epidemic proportions. But while the prevalence of autism spectrum disorder (ASD) has risen since the 1980s, experts say that greater awareness and improved testing are behind the increase in diagnoses. Indeed, a study published this week in JAMA Pediatrics examining birth cohorts finds that the number of children with ASD has held steady. (Holohan, 9/18)

Medical Xpress: Study Reveals Surprising Cause Of Immune Challenges In People With Down Syndrome

Getting sick can look very different for people with Down syndrome (DS); illnesses that are mild for most people may lead to serious complications, including pneumonia, hospitalization or the need for intensive care. (Lock, 9/20)

In other mental healthcare news —

The New York Times: Patrick Clancy Describes Grief In First Interview Since Mistrial 

In an interview broadcast on CBS on Sunday, Patrick Clancy, the former husband of Lindsay Clancy, described the weight of his grief in the years since Ms. Clancy killed their three children in January 2023. (Spoto and Russell, 9/20)

KFF Health News: It’s Hard To Predict Who Will Be Suicidal. It’s Easier To Ensure People Can’t Shoot Themselves

Paul Nestadt is about as steeped in suicide prevention as a person can be. He treats suicidal patients as a psychiatrist, has co-authored scores of research papers on how and why people kill themselves, and teaches graduate courses on the subject. But he’ll be the first to admit: “I can’t tell you which of my patients is likely to die by suicide in the next six months.” Almost nobody can. (Pattani, 9/21)

If you need help —

Dial 988 for 24/7 support from the Suicide & Crisis Lifeline. It's free and confidential.

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, September 21
  • Friday, September 18
  • Thursday, September 17
  • Wednesday, September 16
  • Tuesday, September 15
  • Monday, September 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF